These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21386707)

  • 1. Risk of kidney cancer and chronic kidney disease in relation to hepatitis C virus infection: a nationwide register-based cohort study in Sweden.
    Hofmann JN; Törner A; Chow WH; Ye W; Purdue MP; Duberg AS
    Eur J Cancer Prev; 2011 Jul; 20(4):326-30. PubMed ID: 21386707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden.
    Batyrbekova N; Aleman S; Lybeck C; Montgomery S; Duberg AS
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):63-70. PubMed ID: 31719064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Hepatitis C Virus and Chronic Kidney Disease: A Systematic Review and Meta-Analysis.
    Fabrizi F; Donato FM; Messa P
    Ann Hepatol; 2018; 17(3):364-391. PubMed ID: 29735788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus itself is a causal risk factor for chronic kidney disease beyond traditional risk factors: a 6-year nationwide cohort study across Taiwan.
    Chen YC; Chiou WY; Hung SK; Su YC; Hwang SJ
    BMC Nephrol; 2013 Sep; 14():187. PubMed ID: 24011024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus infection increases risk of developing end-stage renal disease using competing risk analysis.
    Lee JJ; Lin MY; Chang JS; Hung CC; Chang JM; Chen HC; Yu ML; Hwang SJ
    PLoS One; 2014; 9(6):e100790. PubMed ID: 24971499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus infection and the risk of cancer among elderly US adults: A registry-based case-control study.
    Mahale P; Torres HA; Kramer JR; Hwang LY; Li R; Brown EL; Engels EA
    Cancer; 2017 Apr; 123(7):1202-1211. PubMed ID: 28117886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of hospitalization for infection among patients with hepatitis B or C virus infection without cirrhosis in Taiwan: A cohort study.
    Lee YC; Wang JL; Dong YH; Chen HC; Wu LC; Chang CH
    PLoS Med; 2019 Sep; 16(9):e1002894. PubMed ID: 31518344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: Systematic review and meta-analysis.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Med Virol; 2016 Mar; 88(3):487-97. PubMed ID: 26271205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and natural history of hepatitis C virus infection.
    Lee MH; Yang HI; Yuan Y; L'Italien G; Chen CJ
    World J Gastroenterol; 2014 Jul; 20(28):9270-80. PubMed ID: 25071320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.
    Tsui JI; Vittinghoff E; Shlipak MG; Bertenthal D; Inadomi J; Rodriguez RA; O'Hare AM
    Arch Intern Med; 2007 Jun; 167(12):1271-6. PubMed ID: 17592100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins and the risk of hepatocellular carcinoma in patients with hepatitis C virus infection.
    Tsan YT; Lee CH; Ho WC; Lin MH; Wang JD; Chen PC
    J Clin Oncol; 2013 Apr; 31(12):1514-21. PubMed ID: 23509319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C co-infection is associated with an increased risk of incident chronic kidney disease in HIV-infected patients initiating combination antiretroviral therapy.
    Rossi C; Raboud J; Walmsley S; Cooper C; Antoniou T; Burchell AN; Hull M; Chia J; Hogg RS; Moodie EE; Klein MB;
    BMC Infect Dis; 2017 Apr; 17(1):246. PubMed ID: 28376824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical manifestations and outcomes between hepatitis B virus- and hepatitis C virus-related hepatocellular carcinoma: analysis of a nationwide cohort.
    Sinn DH; Gwak GY; Cho J; Paik SW; Yoo BC
    PLoS One; 2014; 9(11):e112184. PubMed ID: 25372403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.
    Singh N; Neidlinger N; Djamali A; Leverson G; Voss B; Sollinger HW; Pirsch JD
    Clin Transplant; 2012; 26(5):684-93. PubMed ID: 22283142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality, Hospitalization, and Quality of Life among Patients with Hepatitis C Infection on Hemodialysis.
    Goodkin DA; Bieber B; Jadoul M; Martin P; Kanda E; Pisoni RL
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):287-297. PubMed ID: 27908905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer risk in patients with hepatitis C virus infection: a population-based study in Sweden.
    Liu X; Chen Y; Wang Y; Dong X; Wang J; Tang J; Sundquist K; Sundquist J; Ji J
    Cancer Med; 2017 May; 6(5):1135-1140. PubMed ID: 28374973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus-Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study.
    Sawinski D; Forde KA; Lo Re V; Goldberg DS; Cohen JB; Locke JE; Bloom RD; Brensinger C; Weldon J; Shults J; Reese PP
    Am J Kidney Dis; 2019 Jun; 73(6):815-826. PubMed ID: 30704882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-Based Treatment of Hepatitis C Virus Infection Reduces All-Cause Mortality in Patients With End-Stage Renal Disease: An 8-Year Nationwide Cohort Study in Taiwan.
    Hsu YH; Hung PH; Muo CH; Tsai WC; Hsu CC; Kao CH
    Medicine (Baltimore); 2015 Nov; 94(47):e2113. PubMed ID: 26632730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk for renal cell carcinoma in chronic hepatitis C infection.
    Gordon SC; Moonka D; Brown KA; Rogers C; Huang MA; Bhatt N; Lamerato L
    Cancer Epidemiol Biomarkers Prev; 2010 Apr; 19(4):1066-73. PubMed ID: 20332260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of immunosuppressive regimen on survival of kidney transplant recipients with hepatitis C.
    Luan FL; Schaubel DE; Zhang H; Jia X; Pelletier SJ; Port FK; Magee JC; Sung RS
    Transplantation; 2008 Jun; 85(11):1601-6. PubMed ID: 18551066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.